Novo Competitors
| NOVO-B Stock | DKK 757.30 9.70 1.30% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Novo Nordisk competition on your existing holdings.
Novo |
Novo Nordisk Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Novo Nordisk and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Novo and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Novo Nordisk AS does not affect the price movement of the other competitor.
| 0.05 | 0.73 | -0.53 | 0.79 | VWS | ||
| 0.05 | 0.24 | -0.5 | -0.32 | DANSKE | ||
| 0.73 | 0.24 | -0.68 | 0.47 | BAVA | ||
| -0.53 | -0.5 | -0.68 | -0.1 | DSV | ||
| 0.79 | -0.32 | 0.47 | -0.1 | ORSTED | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Novo Stock performing well and Novo Nordisk Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Novo Nordisk's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| VWS | 2.25 | (0.42) | 0.00 | 0.62 | 0.00 | 4.05 | 17.28 | |||
| DANSKE | 0.89 | (0.03) | 0.00 | 0.25 | 0.00 | 2.05 | 5.71 | |||
| BAVA | 2.08 | (0.51) | 0.00 | (1.51) | 0.00 | 3.45 | 21.30 | |||
| DSV | 1.14 | 0.39 | 0.20 | (0.69) | 0.59 | 2.66 | 12.28 | |||
| ORSTED | 1.82 | 0.03 | (0.04) | (0.63) | 2.84 | 4.06 | 18.80 |
Novo Nordisk Competitive Analysis
The better you understand Novo Nordisk competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Novo Nordisk's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Novo Nordisk's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Novo Nordisk Competition Performance Charts
Five steps to successful analysis of Novo Nordisk Competition
Novo Nordisk's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Novo Nordisk AS in relation to its competition. Novo Nordisk's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Novo Nordisk in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Novo Nordisk's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Novo Nordisk AS, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Novo Nordisk position
In addition to having Novo Nordisk in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Investment Grade ETFs Thematic Idea Now
Investment Grade ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Investment Grade ETFs theme has 260 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investment Grade ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in Novo Stock
When determining whether Novo Nordisk AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novo Nordisk's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novo Nordisk As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novo Nordisk As Stock:Check out Novo Nordisk Correlation with its peers.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.